Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 77 Pages
Report ld: 4158676
Request Sample
Customized Report
The global market for Icodextrin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
North American market for Icodextrin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Icodextrin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Icodextrin include Baxter, FZBIOTECH, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Icodextrin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Icodextrin.
The Icodextrin market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Icodextrin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Icodextrin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Icodextrin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Icodextrin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Icodextrin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Icodextrin Market Overview
1.1 Product Definition
1.2 Icodextrin by Type
1.2.1 Global Icodextrin Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 7.5% Icodextrin
1.2.3 4% Icodextrin
1.3 Icodextrin by Application
1.3.1 Global Icodextrin Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Ambulatory Peritoneal Dialysis (CAPD)
1.3.3 Automatic Peritoneal Dialysis (APD)
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Icodextrin Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Icodextrin Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Icodextrin Production Estimates and Forecasts (2020-2031)
1.4.4 Global Icodextrin Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Icodextrin Production Market Share by Manufacturers (2020-2025)
2.2 Global Icodextrin Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Icodextrin, Industry Ranking, 2023 VS 2024
2.4 Global Icodextrin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Icodextrin Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Icodextrin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Icodextrin, Product Offered and Application
2.8 Global Key Manufacturers of Icodextrin, Date of Enter into This Industry
2.9 Icodextrin Market Competitive Situation and Trends
2.9.1 Icodextrin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Icodextrin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Icodextrin Production by Region
3.1 Global Icodextrin Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Icodextrin Production Value by Region (2020-2031)
3.2.1 Global Icodextrin Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Icodextrin by Region (2026-2031)
3.3 Global Icodextrin Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Icodextrin Production Volume by Region (2020-2031)
3.4.1 Global Icodextrin Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Icodextrin by Region (2026-2031)
3.5 Global Icodextrin Market Price Analysis by Region (2020-2025)
3.6 Global Icodextrin Production and Value, Year-over-Year Growth
3.6.1 North America Icodextrin Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Icodextrin Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Icodextrin Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Icodextrin Production Value Estimates and Forecasts (2020-2031)
4 Icodextrin Consumption by Region
4.1 Global Icodextrin Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Icodextrin Consumption by Region (2020-2031)
4.2.1 Global Icodextrin Consumption by Region (2020-2025)
4.2.2 Global Icodextrin Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Icodextrin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Icodextrin Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Icodextrin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Icodextrin Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Icodextrin Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Icodextrin Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Icodextrin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Icodextrin Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Icodextrin Production by Type (2020-2031)
5.1.1 Global Icodextrin Production by Type (2020-2025)
5.1.2 Global Icodextrin Production by Type (2026-2031)
5.1.3 Global Icodextrin Production Market Share by Type (2020-2031)
5.2 Global Icodextrin Production Value by Type (2020-2031)
5.2.1 Global Icodextrin Production Value by Type (2020-2025)
5.2.2 Global Icodextrin Production Value by Type (2026-2031)
5.2.3 Global Icodextrin Production Value Market Share by Type (2020-2031)
5.3 Global Icodextrin Price by Type (2020-2031)
6 Segment by Application
6.1 Global Icodextrin Production by Application (2020-2031)
6.1.1 Global Icodextrin Production by Application (2020-2025)
6.1.2 Global Icodextrin Production by Application (2026-2031)
6.1.3 Global Icodextrin Production Market Share by Application (2020-2031)
6.2 Global Icodextrin Production Value by Application (2020-2031)
6.2.1 Global Icodextrin Production Value by Application (2020-2025)
6.2.2 Global Icodextrin Production Value by Application (2026-2031)
6.2.3 Global Icodextrin Production Value Market Share by Application (2020-2031)
6.3 Global Icodextrin Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Baxter
7.1.1 Baxter Icodextrin Company Information
7.1.2 Baxter Icodextrin Product Portfolio
7.1.3 Baxter Icodextrin Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Baxter Main Business and Markets Served
7.1.5 Baxter Recent Developments/Updates
7.2 FZBIOTECH
7.2.1 FZBIOTECH Icodextrin Company Information
7.2.2 FZBIOTECH Icodextrin Product Portfolio
7.2.3 FZBIOTECH Icodextrin Production, Value, Price and Gross Margin (2020-2025)
7.2.4 FZBIOTECH Main Business and Markets Served
7.2.5 FZBIOTECH Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Icodextrin Industry Chain Analysis
8.2 Icodextrin Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Icodextrin Production Mode & Process Analysis
8.4 Icodextrin Sales and Marketing
8.4.1 Icodextrin Sales Channels
8.4.2 Icodextrin Distributors
8.5 Icodextrin Customer Analysis
9 Icodextrin Market Dynamics
9.1 Icodextrin Industry Trends
9.2 Icodextrin Market Drivers
9.3 Icodextrin Market Challenges
9.4 Icodextrin Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Icodextrin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 125
USD 3950.00
(Single User License)
The global Icodextrin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 123
USD 2900.00
(Single User License)
The global Icodextrin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 124
USD 4900.00
(Single User License)
The global Icodextrin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 67
USD 4250.00
(Single User License)
The global market for Icodextrin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 85
USD 3950.00
(Single User License)
Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
Published Date: 2024-04-07
Pages: 71
USD 4900.00
(Single User License)
Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
Published Date: 2024-01-10
Pages: 84
USD 2900.00
(Single User License)
The global market for Icodextrin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 125
The global Icodextrin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 123
The global Icodextrin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 124
The global Icodextrin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 67
The global market for Icodextrin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 85
Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
Published: 2024-04-07
Pages: 71
Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
Published: 2024-01-10
Pages: 84
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now